# Loved and Loathed: The Making of India's Viral Liver Doctor

Dr Cyriac Abby Philips has amassed a devoted following across India's digital health landscape, earning the nickname "The Liver Doc" while simultaneously sparking fierce medical debates. His rise to prominence reflects broader tensions within India's healthcare ecosystem, where evidence-based medicine increasingly confronts traditional practitioners.

Philips, a hepatologist based in Kerala, built his audience by translating complex liver science into accessible content for millions of Indians. His posts on alcohol-related liver disease, hepatitis, and cirrhosis reach audiences who might otherwise lack access to specialist care. Many patients credit his free online guidance with early diagnosis and treatment-seeking behavior.

Yet this visibility has made him a controversial figure. Traditional medicine specialists, particularly Ayurveda practitioners, have publicly criticized Philips for what they view as dismissive attitudes toward their centuries-old systems. The conflicts grew heated enough to garner media attention and regulatory scrutiny. Philips has defended his positions by pointing to clinical evidence, arguing that patient safety demands clear communication about which treatments carry scientific validation.

The tensions reflect India's unique healthcare landscape. The country recognizes multiple medical systems officially. Ayurveda, Unani, and Siddha practitioners operate alongside allopathic doctors, sometimes creating confusion for patients navigating competing claims about treatment effectiveness. Philips occupies the role of translator and, increasingly, arbiter of medical truth on social media platforms where misinformation spreads as readily as accurate information.

His supporters view him as a necessary voice cutting through medical mythology. His critics argue he dismisses valuable traditional knowledge without acknowledging its potential benefits. The debate extends beyond personalities into questions about medical authority in the digital age. Who decides what constitutes legitimate health information when millions scroll past competing claims daily?

Philips continues producing content